Barbara McGowan - Concepedia

Author

Barbara McGowan

Guy's and St Thomas' NHS Foundation Trust ORCID

Also Known As

B M C McGowan, B M McGowan, B MCGOWAN, B McGOWAN, B McGowan, B Mcgowan, B. M. C. McGowan, B. M. McGowan, B. McGOWAN, B. McGowan

225

Publications

11.2K

Citations

H-Index

Concepts

All Affiliations

Guy's and St Thomas' NHS Foundation Trust Imperial College London University College London Hammersmith Hospital King's College London

About

Barbara McGowan is an author at Guy's and St Thomas' NHS Foundation Trust specializing in medicine, health sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	2.6K
2	Health Sciences	8	8	1.5K
3	Education	2	2	59
4	Humanities	1	1	12
5	Language Studies	1	1	15

Barbara McGowan

Publications

9.5K

Citations

H-Index

Page 1

	Year	Citations
Once-Weekly Semaglutide in Adults with Overweight or Obesity John Wilding, Rachel L. Batterham, Salvatore Calanna, New England Journal of Medicine	2021	3.9K
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Carel W. le Roux, Arne Astrup, Ken Fujioka, The Lancet ObesityMetabolic SyndromeNutritionDiabetes ManagementLiraglutide Versus Placebo	2017	813
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension John Wilding, Rachel L. Batterham, Melanie J. Davies, Diabetes Obesity and Metabolism	2022	766
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan, The Lancet ObesityNon-pharmacological InterventionWeight LossPharmacologyClinical Trials	2018	751
Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males Waljit S. Dhillo, Owais B. Chaudhri, Michael Patterson, The Journal of Clinical Endocrinology & Metabolism	2005	649
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial David C.W. Lau, Lars Erichsen, Ann Marie Ocampo Francisco, The Lancet ObesityMetabolic SyndromeDose-finding Phase 2Non-pharmacological InterventionLifestyle Modification	2021	211
Central Relaxin-3 Administration Causes Hyperphagia in Male Wistar Rats Barbara McGowan, Sarah A. Stanley, K. L. Smith, Endocrinology Food IntakeGastrointestinal Peptide HormoneFood Intake 1Neuroendocrine MechanismHypothalamic Peptide	2005	182
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial Alexander D. Miras, Belén Pérez‐Pevida, Madhawi Aldhwayan, The Lancet Diabetes & Endocrinology	2019	170
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in<i>AIP</i>Mutation Carriers Laura C. Hernández‐Ramírez, Plamena Gabrovska, Judit Dénes, The Journal of Clinical Endocrinology & Metabolism	2015	167
One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk Andrew Wister, Nils A. Loewen, Holly Kennedy-Symonds, Canadian Medical Association Journal	2007	148

Page 1